[Federal Register Volume 67, Number 131 (Tuesday, July 9, 2002)]
[Notices]
[Page 45524]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-17162]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[Program Announcement  02123]


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel: Multi-Level Parent Training Effectiveness Trial, 
Program Announcement 02072, and Parenting Program Attrition 
and Compliance Efficacy Trial

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following meeting:
    Name: Disease, Disability, and Injury Prevention and Control 
Special Emphasis Panel (SEP): Multi-Level Parent Training Effectiveness 
Trial, Program Announcement 02072, and Parenting Program 
Attrition and Compliance Efficacy Trial, Program Announcement 
02123.
    Times and Dates: 6 p.m.-6:30 p.m., July 28, 2002 (Open); 6:30 p.m.-
8 p.m., July 28, 2002 (Closed); 8:30 a.m.-5 p.m., July 29, 2002 
(Closed).
    Place: The Westin Hotel (Atlanta Airport), 4736 Best Road, Atlanta, 
GA 30337, Phone: (404) 762-7676.
    Status: Portions of the meeting will be closed to the public in 
accordance with provisions set forth in section 552b(c) (4) and (6), 
Title 5 U.S.C., and the Determination of the Director, Management 
Analysis and Services Office, CDC, pursuant to Public Law 92-463.
    Matters to be Discussed: The meeting will include the review, 
discussion, and evaluation of applications received in response to 
PA 02072 & PA 02123.
    Contact Person for More Information: Dr. Joanne Klevens, 
Epidemiologist, National Center for Injury Prevention and Control, CDC, 
2939 Flowers Road, Atlanta, Georgia 30341; (770) 488-4330.
    The Director, Management Analysis and Services Office has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention and the Agency 
for Toxic Substances and Disease Registry.

    Dated: July 2, 2002.
Joe Salter,
Acting Director, Management Analysis and Services Office, , Centers for 
Disease Control and Prevention (CDC).
[FR Doc. 02-17162 Filed 7-8-02; 8:45 am]
BILLING CODE 4163-18-P